These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer. Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232 [TBL] [Abstract][Full Text] [Related]
37. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer. Bui KT; Willson ML; Goel S; Beith J; Goodwin A Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074 [TBL] [Abstract][Full Text] [Related]
38. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. McBain C; Lawrie TA; Rogozińska E; Kernohan A; Robinson T; Jefferies S Cochrane Database Syst Rev; 2021 May; 5(1):CD013579. PubMed ID: 34559423 [TBL] [Abstract][Full Text] [Related]
39. Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer. Wei D; Heus P; van de Wetering FT; van Tienhoven G; Verleye L; Scholten RJ Cochrane Database Syst Rev; 2018 Aug; 8(8):CD008831. PubMed ID: 30168576 [TBL] [Abstract][Full Text] [Related]
40. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review. Narayan V; Kahlmeyer A; Dahm P; Skoetz N; Risk MC; Bongiorno C; Patel N; Hwang EC; Jung JH; Gartlehner G; Kunath F Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012838. PubMed ID: 30036453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]